Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge

The National Institutes of Health is launching the Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge to seek innovative approaches that modulate RNA for disease treatment.  

The challenge will support solutions that improve how we target, edit, degrade or modulate RNA in our cells to advance human health. 

TRDNT Challenge Phase 1 will open for submissions on March 30.